GEN Exclusives

More »

GEN News Highlights

More »
Aug 14, 2008

TGen to Assess febit’s DNA Capture Method in Next-Generation Sequencing Efforts

  • Translational Genomics Research Institute (TGen) will febit's HybSelect™ in next-generation sequencing equipment. The partnership thus provides TGen scientists premarket access to this technology, which is a method for capturing DNA.

    “We will obtain important data from TGen that will help us as we prepare for the official introduction of HybSelect in early 2009,” says Cord F. Staehler, president of febit.

    HybSelect enables selective DNA capture and elution, an efficient method to preselect sequences for next-generation sequencers, the companies report. It is based on febit's Geniom Technology and uses arrays within microfluidic biochips for the selection process of targeted DNA. Geniom biochips are programmable and can contain any desired set of capture probes.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?